Current filters:  
United States
M&A/Private Equity
United States
Akin Gump Strauss Hauer & Feld LLP
The COVID-19 pandemic and its related economic shock are causing huge challenges for companies of all sizes, geographies and industries
Ropes & Gray LLP
On Sunday afternoon, March 22, 2020, the Senate failed to pass a key procedural vote required to advance the Coronavirus Aid, Relief, and Economic Security Act ...
Shearman & Sterling LLP
With each passing day, the global economic climate plunges further into uncharted waters as the world attempts to construct a public health response sufficient to slow the progress of the COVID-19 pandemic.
WilmerHale
For most private equity sponsors and their portfolio companies, the effects of the COVID-19 shockwave have started to give way to the realization that, for the near term, uncertainty is the new normal.
Mayer Brown
M&A partners and co-leaders of Mayer Brown's Transactional Liability Insurance practice Joe Castelluccio and William Kucera, along with Litigation & Dispute Resolution partner Robert Harrell and associate Andrew Elkhoury, ...
Akin Gump Strauss Hauer & Feld LLP
Projections of the full impact of COVID-19 (more commonly known as the coronavirus) on the economy remain extremely uncertain and continue to reflect a variety of outcomes.
Buchanan Ingersoll & Rooney PC
As a founder of a startup, receiving your first venture capital term sheet can be one of the most exciting times in the early life of your company.
Cooley LLP
In light of COVID-19 and the economic impact of measures taken to control its spread, borrowers are reviewing terms of existing credit facilities...
Cleary Gottlieb Steen & Hamilton LLP
As the situation with COVID-19 continues to evolve, we will be regularly updating this chart that uses the best information available to us to track the status of the world's antitrust agencies.
Buchanan Ingersoll & Rooney PC
For founders, a successful M&A exit can be a great reward for years of entrepreneurial growth.
Cooley LLP
While the federal antitrust agencies, the Federal Trade Commission and US Department of Justice (the agencies), are still open for business, the agencies are experiencing significant disruption due to the COVID-19 pandemic.
Mayer Brown
Our COVID-19 web portal is a one-stop resource center that aggregates the latest Mayer Brown legal updates and insights on COVID-19.
Shipman & Goodwin LLP
On January 10, 2020, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) announced proposed draft Vertical Merger Guidelines ("Draft Guidelines") for public comment.
Foley & Lardner
On February 27th, the Federal Trade Commission (FTC) and the Attorney General of the Commonwealth of Pennsylvania (AG)
Proskauer Rose LLP
The unexpected emergence of the COVID-19 virus presents a wide range of new challenges and opportunities. The initial reaction of the syndicated market has been to pull back.
Arnold & Porter
In this chapter, co-authored with Adrian M. Schell, Dr. Freier examines the key legal issues surrounding private equity investments in the biotech/pharma industry.
Fenwick & West LLP
The myriad and rapidly evolving impacts of COVID-19, the disease caused by the novel coronavirus, are being felt across society—in the healthcare system, employment, politics and the economy.
Holland & Knight
Holland & Knight has established a COVID-19 Response Team to help clients respond to a variety of business and legal issues they may be facing related to the disease.
Worldwide
Ropes & Gray LLP
In this Ropes & Gray podcast, finance partner Leonard Klingbaum leads a discussion on the impact COVID-19 is having on various practice areas across the globe.
Akin Gump Strauss Hauer & Feld LLP
As of March 17, 2020, the FTC and DOJ will accept only electronic submissions of HSR notifications (no filings accepted March 16, 2020).
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Popular Authors
Tools
Font Size:
Translation
Mondaq Social Media